FIELD: biotechnology.
SUBSTANCE: disclosed is a composition for treating Clostridium dificile diarrhea in a mammal, containing three or more purified species of spore-forming bacteria. Also disclosed is a method of treating Clostridium Difficile diarrhea in a mammal, comprising administering said composition to the mammal.
EFFECT: invention provides effective treatment of Clostridium Difficile diarrhea in a mammal.
11 cl, 21 dwg, 33 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS FOR PREPARING AND USING THEM | 2014 |
|
RU2722482C2 |
| COMPONENTS OF THE CRISPR-CAS SYSTEM, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796549C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND USE IN THERAPY | 2013 |
|
RU2721275C2 |
| SYSTEM DESIGN, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796017C2 |
| METHOD OF AMPLIFICATION AND IDENTIFICATION OF NUCLEIC ACIDS | 2019 |
|
RU2811465C2 |
| CRISPR-CAS SYSTEMS AND METHODS FOR CHANGING THE EXPRESSION OF GENE PRODUCTS | 2013 |
|
RU2796273C2 |
| DEVELOPED BACTERIAL COMPOSITIONS | 2016 |
|
RU2773327C2 |
| CRISPR ENZYME MUTATIONS REDUCING NON-TARGETED EFFECTS | 2016 |
|
RU2752834C2 |
| TRIPTAMIN METABOLISM MANIPULATION | 2018 |
|
RU2794244C2 |
| GENOME ENGINEERING | 2021 |
|
RU2812848C2 |
